Cue Biopharma, Inc. (CUE) Earning

NASDAQ Currency in USD Disclaimer

$1.01

south_east -$0.03 (-2.88%)
Day's range
$0.98
Day's range
$1.05

Cue Biopharma, Inc. Analyst EPS Estimates

Quarter Number of Estimates Low Estimate High Estimate Average Estimate
Q1 2024 1 -$0.28 -$0.28 -$0.28
Q2 2024 1 -$0.28 -$0.28 -$0.28
Q3 2024 1 -$0.18 -$0.18 -$0.18
Q4 2024 3 -$0.11 -$0.06 -$0.09
Q1 2025 2 -$0.18 -$0.14 -$0.16
Q2 2025 1 -$0.14 -$0.14 -$0.14
Q3 2025 1 -$0.13 -$0.13 -$0.13
Q4 2025 1 -$0.14 -$0.14 -$0.14

Cue Biopharma, Inc. Earnings Date And Information

Cue Biopharma, Inc. last posted its earnings results on Wednesday, August 14th, 2024. The company reported $-0.2 earnings per share for the quarter, topping analysts' consensus estimates of $-0.29 by $0.09. The company had revenue of 3.34 M for the quarter and had revenue of 5.49 M for the year. Cue Biopharma, Inc. has generated $-1 earnings per share over the last year ($-1.11 diluted earnings per share) and currently has a price-to-earnings ratio of -1.16. Cue Biopharma, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 12th, 2025 based on prior year's report dates.

Cue Biopharma, Inc. Earnings History by Quarter

Date Quarter Consensus Estimate Reported EPS Beat/Miss Revenue Estimate Actual Revenue
11/14/2024 Q3 2024 -$0.17 $1.52 M $3.34 M
08/14/2024 Q2 2024 -$0.29 -$0.20 0.09 $1.29 M $2.66 M
05/09/2024 Q1 2024 -$0.30 -$0.25 0.05 $1.72 M
12/29/2023 Q4 2023 -$0.28 $1.82 M
11/03/2023 Q3 2023 -$0.24 $1.31 M $2.10 M
08/08/2023 Q2 2023 -$0.30 -$0.29 0.01 $907,500 $1.38 M
05/09/2023 Q1 2023 -$0.33 -$0.30 0.03 $187,000
03/21/2023 Q4 2022 -$0.32 -$0.37 -0.05 $151,227
11/14/2022 Q3 2022 -$0.38 -$0.31 0.07 $513,499 $68,000
08/04/2022 Q2 2022 -$0.42 -$0.38 0.04 $1.13 M $26,000
05/10/2022 Q1 2022 -$0.43 -$0.44 -0.01 $1.00 M
03/16/2022 Q4 2021 -$0.27 $8.25 M
11/09/2021 Q3 2021 -$0.39 -$0.41 -0.02 $2.40 M $2.40 M
08/09/2021 Q2 2021 -$0.42 -$0.33 0.09 $1.06 M $2.74 M
05/10/2021 Q1 2021 -$0.41 $1.55 M
03/09/2021 Q4 2020 -$0.37 $475,325
11/09/2020 Q3 2020 -$0.34 $1.27 M $704,000
08/07/2020 Q2 2020 -$0.41 -$0.38 0.03 $930,000 $1.08 M
05/07/2020 Q1 2020 -$0.32 -$0.48 -0.16 $900,000
03/11/2020 Q4 2019 -$0.37 $1.05 M
 

Cue Biopharma, Inc. Earnings: FAQ's

When is Cue Biopharma, Inc.'s earnings date?

Cue Biopharma, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 12th, 2025 based off last year's report dates.

Did Cue Biopharma, Inc. beat their earnings estimates last quarter?

In the previous quarter, Cue Biopharma, Inc. (:CUE) reported $-0.2 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.29 by $0.09.

How can I listen to Cue Biopharma, Inc.'s earnings conference call?

The conference call for Cue Biopharma, Inc.'s latest earnings report can be listened to online.

How can I read Cue Biopharma, Inc.'s conference call transcript?

The conference call transcript for Cue Biopharma, Inc.'s latest earnings report can be read online.

How much revenue does Cue Biopharma, Inc. generate each year?

Cue Biopharma, Inc. (:CUE) has a recorded annual revenue of $5.49 M.

How much profit does Cue Biopharma, Inc. generate each year?

Cue Biopharma, Inc. (:CUE) has a recorded net income of $5.49 M. Cue Biopharma, Inc. has generated $-1.11 earnings per share over the last four quarters.

What is Cue Biopharma, Inc.'s price-to-earnings ratio?

Cue Biopharma, Inc. (:CUE) has a price-to-earnings ratio of -1.16 and price/earnings-to-growth ratio is -0.16.

Portfolio Sync
Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED